SAT-035 Small Molecule Allosteric Agonist of Relaxin Receptor Ml290 Demonstrates Antifibrotic Properties in Liver Fibrosis Article

Kaftanovskaya, Elena, Ng, Hooi Hooi, Rivas, Bryan et al. (2019). SAT-035 Small Molecule Allosteric Agonist of Relaxin Receptor Ml290 Demonstrates Antifibrotic Properties in Liver Fibrosis . 3(Suppl 1), sat-035. 10.1210/js.2019-sat-035

cited authors

  • Kaftanovskaya, Elena; Ng, Hooi Hooi; Rivas, Bryan; Myhr, Courtney; Shupe, Thomas; Hu, Xin; Ferrer, Marc; Southall, Noel; Wilson, Kenneth; Marugan, Juan; Bishop, Colin; Agoulnik, Irina; Agoulnik, Alexander

authors

publication date

  • April 15, 2019

keywords

  • 2 Aetiology
  • 2.1 Biological and endogenous factors
  • 32 Biomedical and Clinical Sciences
  • 3201 Cardiovascular Medicine and Haematology
  • 5 Development of treatments and therapeutic interventions
  • 5.1 Pharmaceuticals
  • Chronic Liver Disease and Cirrhosis
  • Digestive Diseases
  • Genetics
  • Liver Disease
  • Oral and gastrointestinal

Digital Object Identifier (DOI)

publisher

  • The Endocrine Society

start page

  • sat

end page

  • 035

volume

  • 3

issue

  • Suppl 1